391 related articles for article (PubMed ID: 22474370)
1. Mouse model recapitulating human Fcγ receptor structural and functional diversity.
Smith P; DiLillo DJ; Bournazos S; Li F; Ravetch JV
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6181-6. PubMed ID: 22474370
[TBL] [Abstract][Full Text] [Related]
2. N-linked glycan structures of the human Fcγ receptors produced in NS0 cells.
Cosgrave EF; Struwe WB; Hayes JM; Harvey DJ; Wormald MR; Rudd PM
J Proteome Res; 2013 Aug; 12(8):3721-37. PubMed ID: 23777450
[TBL] [Abstract][Full Text] [Related]
3. Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
Tutt AL; James S; Laversin SA; Tipton TR; Ashton-Key M; French RR; Hussain K; Vaughan AT; Dou L; Earley A; Dahal LN; Lu C; Dunscombe M; Chan HT; Penfold CA; Kim JH; Potter EA; Mockridge CI; Roghanian A; Oldham RJ; Cox KL; Lim SH; Teige I; Frendéus B; Glennie MJ; Beers SA; Cragg MS
J Immunol; 2015 Dec; 195(11):5503-16. PubMed ID: 26512139
[TBL] [Abstract][Full Text] [Related]
4. Fcγ receptor pathways during active and passive immunization.
Bournazos S; Ravetch JV
Immunol Rev; 2015 Nov; 268(1):88-103. PubMed ID: 26497515
[TBL] [Abstract][Full Text] [Related]
5. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms.
Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G
Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585
[TBL] [Abstract][Full Text] [Related]
7. IgG Fc Receptors: Evolutionary Considerations.
Bournazos S
Curr Top Microbiol Immunol; 2019; 423():1-11. PubMed ID: 30739161
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
Caaveiro JM; Kiyoshi M; Tsumoto K
Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
[TBL] [Abstract][Full Text] [Related]
9. An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.
Wilson NS; Yang B; Yang A; Loeser S; Marsters S; Lawrence D; Li Y; Pitti R; Totpal K; Yee S; Ross S; Vernes JM; Lu Y; Adams C; Offringa R; Kelley B; Hymowitz S; Daniel D; Meng G; Ashkenazi A
Cancer Cell; 2011 Jan; 19(1):101-13. PubMed ID: 21251615
[TBL] [Abstract][Full Text] [Related]
10. A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors.
Corrales-Aguilar E; Trilling M; Reinhard H; Mercé-Maldonado E; Widera M; Schaal H; Zimmermann A; Mandelboim O; Hengel H
J Immunol Methods; 2013 Jan; 387(1-2):21-35. PubMed ID: 23023090
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody-mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade.
Auger JL; Haasken S; Binstadt BA
Arthritis Res Ther; 2012 Dec; 14(6):R269. PubMed ID: 23237573
[TBL] [Abstract][Full Text] [Related]
12. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
[TBL] [Abstract][Full Text] [Related]
13. Monovalent Fc receptor blockade by an anti-Fcγ receptor/albumin fusion protein ameliorates murine ITP with abrogated toxicity.
Yu X; Menard M; Prechl J; Bhakta V; Sheffield WP; Lazarus AH
Blood; 2016 Jan; 127(1):132-8. PubMed ID: 26500340
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils mediate antibody-induced antitumor effects in mice.
Albanesi M; Mancardi DA; Jönsson F; Iannascoli B; Fiette L; Di Santo JP; Lowell CA; Bruhns P
Blood; 2013 Oct; 122(18):3160-4. PubMed ID: 23980063
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice.
Boross P; Jansen JH; van Tetering G; Nederend M; Brandsma A; Meyer S; Torfs E; van den Ham HJ; Meulenbroek L; de Haij S; Leusen JH
Immunol Lett; 2014 Aug; 160(2):151-7. PubMed ID: 24613852
[TBL] [Abstract][Full Text] [Related]
16. Diversification of IgG effector functions.
Bournazos S; Ravetch JV
Int Immunol; 2017 Jul; 29(7):303-310. PubMed ID: 28472280
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.
Ortiz DF; Lansing JC; Rutitzky L; Kurtagic E; Prod'homme T; Choudhury A; Washburn N; Bhatnagar N; Beneduce C; Holte K; Prenovitz R; Child M; Killough J; Tyler S; Brown J; Nguyen S; Schwab I; Hains M; Meccariello R; Markowitz L; Wang J; Zouaoui R; Simpson A; Schultes B; Capila I; Ling L; Nimmerjahn F; Manning AM; Bosques CJ
Sci Transl Med; 2016 Nov; 8(365):365ra158. PubMed ID: 27856797
[TBL] [Abstract][Full Text] [Related]
18. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
[TBL] [Abstract][Full Text] [Related]
19. IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse Model.
Bernardo L; Yu H; Amash A; Zimring JC; Lazarus AH
J Immunol; 2015 Sep; 195(5):2224-30. PubMed ID: 26188060
[TBL] [Abstract][Full Text] [Related]
20. Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.
Jung ST; Reddy ST; Kang TH; Borrok MJ; Sandlie I; Tucker PW; Georgiou G
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):604-9. PubMed ID: 20080725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
